Morepen LaboratoriesNSE:MOREPENLAB +2.00%74 Days Inventory is 82.81 as of Mar. 2026, which is 8% above its 10-year median of 76.59. GuruFocus rates NSE:MOREPENLAB with a GF Score™ of 74/100 and a GF Value™ of ₹50.02 (Fairly Valued). The stock has 6 warning signs investors should review. Among 916 Drug Manufacturers companies, Morepen Laboratories ranks better than 83.3% on this metric.
The historical rank and industry rank for Morepen Laboratories's Days Inventory or its related term are showing as below:
NSE:MOREPENLAB'
s Days Inventory Range Over the Past 10 Years
Min: 53.12 Med: 76.59 Max: 94.93
Current: 91.4
During the past 13 years, Morepen Laboratories's highest Days Inventory was 94.93. The lowest was 53.12. And the median was 76.59.
NSE:MOREPENLAB's Days Inventory is ranked better than 83.3% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs NSE:MOREPENLAB: 91.40
Morepen Laboratories's Days Inventory
declined
from Mar. 2025 (86.69) to Mar. 2026 (82.81).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Morepen Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.10.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Morepen Laboratories's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.56.
Morepen Laboratories (NSE:MOREPENLAB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Morepen Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Morepen Laboratories's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Morepen Laboratories Days Inventory Related Terms
Morepen Laboratories Days Inventory Historical Data
* Premium members only.
The historical data trend for Morepen Laboratories's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Morepen Laboratories's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Morepen Laboratories Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Morepen Laboratories's Days Inventory distribution charts can be found below:
* The bar in red indicates where Morepen Laboratories's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Morepen Laboratories (NSE:MOREPENLAB) has a Days Inventory of 82.81 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Morepen Laboratories and its competitors. This is near median its historical median of 76.59. Over the past decade, Morepen Laboratories' Days Inventory has ranged from 53.12 to 94.93. According to the industry distribution chart, Morepen Laboratories ranks #153 out of 916 companies in the Drug Manufacturers industry, placing it in the top 16.7%.
Is Morepen Laboratories' Days Inventory too high?
Morepen Laboratories' current Days Inventory of 82.81 is near median its 10-year median of 76.59. Over the past 10 years, this metric has ranged from a low of 53.12 to a high of 94.93. The Drug Manufacturers industry median Days Inventory is 164.43. Morepen Laboratories' value of 82.81 is 49.6% below this industry median. Based on the distribution chart, Morepen Laboratories ranks #153 out of 916 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Morepen Laboratories has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Morepen Laboratories' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Morepen Laboratories ranks #153 out of 916 companies for Days Inventory. This places Morepen Laboratories in the top 17% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.43. Morepen Laboratories' value of 82.81 is 49.6% below this benchmark. Historically, Morepen Laboratories' own Days Inventory has ranged from 53.12 to 94.93 over the past decade. While the company's 10-year median is 76.59 vs. the industry median of 164.43, Morepen Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Morepen Laboratories's current Days Inventory of 82.81 is 49.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Morepen Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Morepen Laboratories's current Days Inventory is 82.81, which is near median its own 10-year median of 76.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Morepen Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Morepen Laboratories (NSE:MOREPENLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹50.02, compared to a current price of ₹53.16 — trading 6.3% above its estimated fair value. The current Days Inventory is 82.81, which is near median its 10-year median of 76.59 and 49.6% below the Drug Manufacturers industry median of 164.43. Morepen Laboratories' overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Morepen Laboratories (NSE:MOREPENLAB), the current Days Inventory is 82.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Morepen Laboratories (NSE:MOREPENLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Morepen Laboratories stock appears to be overvalued.
The current stock price of ₹53.16 is trading 6.3% above its estimated GF Value™ of ₹50.02.
GuruFocus considers Morepen Laboratories to be Fairly Valued.
Key valuation signals for NSE:MOREPENLAB:
Days Inventory: 82.81 (near median its 10-year median of 76.59)
GF Value™: ₹50.02 vs. price of ₹53.16 (6.3% above fair value)
Industry Position: 49.6% below the Drug Manufacturers median (#153 of 916)
No single metric tells the full story. See the NSE:MOREPENLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.
74GF Score
Get the complete analysis for NSE:MOREPENLAB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MOREPENLAB has been successfully added to your 
